94 Simplifying Presbyopia Correction1-9 The First-of-its-kind presbyopia-correcting IOL with wavefront-shaping technology and a clinically proven monofocal visual disturbances profile1-4 References: 1. AcrySof® IQ Vivity® Extended Vision IOL Directions for Use. 2. Alcon Data on File, US Patent 9968440 B2, May 15, 2018. 3. Alcon Data on File, TDOC0055575. 09 Apr 2019. 4. Alcon Data on File. TDOC-0055576. 23-Jul-2019. 5. Alcon Data on File, TDOC-0056718. 18-Jun-2019. 6. Ligabue E, et al. ACRYSOF IQ VIVITY: Natural vision at a range of distances provided by a novel optical technology. Cataract & Refractive Surgery Today. April 2020 // 7. Alcon Data on file. A02062-REP-043696, Optical Evaluations of Alcon Vivity®, Symfony*, Zeiss* AT LARA* AT LISA IOLs. Feb 2020. 8. Lawless M. Insight news. “An IOL to change the cataract surgery paradigm?” available at “https://www.insightnews.com.au/an-iol-to-change-the-cataract-surgery-paradigm/”. Accessed Date 17.07.2020. 9. Ike K. Ahmed, et al. The Vivity Extended Depth of Focus IOL: Our Clinical Experience. Cataract & Refractive Surgery Today. February 2021// Please refer to product direction for use for complete list of indications, contraindications and warnings. © 2021 Alcon Inc. 8/21 ASIA-VIV-2100019 AcrySof IQ Vivity® IOL
RkJQdWJsaXNoZXIy Njk2NTg0